guest ::
| Home > Publications database > Long-term diuretic medication is an independent predictor of posthepatectomy liver failure > print |
| Home > Publications database > Long-term diuretic medication is an independent predictor of posthepatectomy liver failure > print |
| 001 | 300190 | ||
| 005 | 20250411082136.0 | ||
| 024 | 7 | _ | |a 10.1016/j.gassur.2025.102035 |2 doi |
| 024 | 7 | _ | |a pmid:40154837 |2 pmid |
| 024 | 7 | _ | |a 1091-255X |2 ISSN |
| 024 | 7 | _ | |a 1873-4626 |2 ISSN |
| 037 | _ | _ | |a DKFZ-2025-00667 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Betzler, Alexander |b 0 |
| 245 | _ | _ | |a Long-term diuretic medication is an independent predictor of posthepatectomy liver failure |
| 260 | _ | _ | |a [Amsterdam] |c 2025 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1744352430_27546 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:B440# / 2025 Mar 26;29(5):102035 |
| 520 | _ | _ | |a Posthepatectomy liver failure (PHLF) is the most fatal complication following liver resection, particularly, in patients with comorbidities. This study aimed to assess the impact of long-term medication on PHLF incidence after open liver resections.A retrospective analysis of 682 patients who underwent elective open hepatectomies between 2008 and 2015 at two academic centers was performed. Preoperative, intraoperative, and postoperative data were collected, including long-term medication. Risk factors for the development of PHLF and other postoperative complications were evaluated using univariate and multivariable logistic regression analyses.PHLF occurred in 11.9% (n=81) of patients, with a higher incidence in those taking diuretics as long-term medication (17.7% vs. 5.3%, P < 0.001). Diuretic use was identified as a strong independent risk factor for PHLF (OR 3.8, 95%CI 2.1 - 7.0, P < 0.001), alongside liver cirrhosis (OR 3.8, 95%CI 1.9 - 7.6, P < 0.001), primary liver malignancies (OR 3.8, 95%CI 1.6 - 9.3, P < 0.001), major hepatectomies (OR 3.1, 95%CI 1.7 - 5.7, P < 0.001) and long operating time (OR 4.2, 95% CI 2.4 - 7.2, P < 0.001). Patients with long-term diuretic intake were older, had higher BMIs, and more comorbidities, including liver cirrhosis.Long-term diuretic use is associated with a significantly increased risk of PHLF after open hepatectomy. |
| 536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a ISGLS |2 Other |
| 650 | _ | 7 | |a comedication |2 Other |
| 650 | _ | 7 | |a comorbidity |2 Other |
| 650 | _ | 7 | |a hepatectomy |2 Other |
| 650 | _ | 7 | |a multimorbidity |2 Other |
| 700 | 1 | _ | |a Betzler, Johanna |0 P:(DE-He78)79e2e48100b40ab9f33fb2cb119d6f07 |b 1 |e First author |u dkfz |
| 700 | 1 | _ | |a Bogner, Andreas |b 2 |
| 700 | 1 | _ | |a Walther, Elene |b 3 |
| 700 | 1 | _ | |a Rahbari, Mohammad |b 4 |
| 700 | 1 | _ | |a Reissfelder, Christoph |b 5 |
| 700 | 1 | _ | |a Riediger, Carina |b 6 |
| 700 | 1 | _ | |a Weitz, Jürgen |b 7 |
| 700 | 1 | _ | |a Rahbari, Nuh N |b 8 |
| 700 | 1 | _ | |a Birgin, Emrullah |b 9 |
| 773 | _ | _ | |a 10.1016/j.gassur.2025.102035 |g p. 102035 - |0 PERI:(DE-600)2057634-1 |n 5 |p 102035 |t Journal of gastrointestinal surgery |v 29 |y 2025 |x 1091-255X |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:300190 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)79e2e48100b40ab9f33fb2cb119d6f07 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2025-01-07 |w ger |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2025-01-07 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J GASTROINTEST SURG : 2022 |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2025-01-07 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2025-01-07 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-07 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2025-01-07 |
| 920 | 1 | _ | |0 I:(DE-He78)B440-20160331 |k B440 |l NWG-KKE Translationale Gastrointestinale Onkologie und präklinische Modelle |x 0 |
| 920 | 0 | _ | |0 I:(DE-He78)B440-20160331 |k B440 |l NWG-KKE Translationale Gastrointestinale Onkologie und präklinische Modelle |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B440-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|